Erratum: The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: An analysis of trends in Australia, New Zealand, and England (Cancer Causes and Control (2013) 24 (1727-1736) DOI 10.1007/s10552-013-0250-9));The impact of a two-versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: An analysis of trends in Australia, New Zealand, and England

Cancer Causes and Control

Volumn 24, Issue 9, 2013, Pages 1727-1736

  Simonella, Leonardo ^a,b,c   Canfell, Karen ^a,b,d  

^a CANCER RESEARCH DIVISION   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; Cervical screening; England; Incidence; Mortality; New Zealand; Screening interval

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEW ZEALAND; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; TREND STUDY; UNITED KINGDOM; UTERINE CERVIX CANCER;

ADULT; AGED; AUSTRALIA; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MORTALITY; NEW ZEALAND; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84881543933     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0276-z     Document Type: Erratum

References (57)

1. National Screening Unit (2011) National Cervical Screening Programme. New Zealand Government National Screening Unit. http://www.nsu.govt.nz/current-nsu- programmes/908.asp. Accessed 5th Feb 2011
2. Australian Government Department of Health and Ageing (2009) National Cervical Screening Program. Australian Government Department of Health and Ageing. http://www.cervicalscreen.health.gov.au/internet/screening/publishing. nsf/Content/cervical-about. Accessed 5th Feb 2011
3. Patnick J (2000) Cervical cancer screening in England. Eur J cancer (Oxford, England: 1990) 36(17):2205-2208
4. ACIM (Australian Cancer Incidence and Mortality) Books (2010) AIHW. http://www.aihw.gov.au/cancer/data/acim-books/index.cfm. Accessed 7th Feb 2011
5. Ministry of health data and statistics cancer: historical summary 1948-2007. Ministry of Health. http://www.moh.govt.nz/moh.nsf/indexmh/ dataandstatistics-subjects-cancer-historicalsummary-1948-2007. Accessed Feb 2011
6. Office of National Statistics (2009) Cancer Statistics Registrations: registrations of cancer diagnosed in 2007, England. Series MB1 No. 38. Office of National Statistics, London, UK
7. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet] (2010) International agency for research on cancer. http://globocan.iarc.fr. Accessed 8th Aug 2010
8. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes (1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes. Br Med J (Clin Res Ed) 293 (6548):659-664
9. Cervix cancer screening/IARC Working Group on the Evaluation of Cancer Preventive Strategies (2005) Chapters 5-8: effectiveness of screening in populations; Summary; Evaluation; Recommendations. In, vol 10. IARC Press, Lyon, France, pp 201-241
10. Sasieni P, Adams J, Cuzick J (2003) Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 89(1):88-93
11. Anttila A, Ronco G, (2009) Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union within the European Network for Information on Cancer (EUNICE) Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J cancer (Oxford, England: 1990) 45(15): 2685-2708
12. Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, Nicula F, Vass L, Valerianova Z, Voti L, Sauvaget C, Ronco G (2009) Cervical cancer screening policies and coverage in Europe. Eur J cancer (Oxford, England: 1990) 45(15):2649-2658
13. Australian Government: Department of Health and Ageing (2012) National Cervical Screening Program Renewal. Australian Government: Department of Health and Ageing. Accessed 2012
14. Canfell K, Sitas F, Beral V (2006) Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med J Aust 185(9):482-486
15. Creighton P, Lew JB, Clements M, Smith M, Howard K, Dyer S, Lord S, Canfell K (2010) Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health 10:734
16. World Health Organization (2010) WHO Mortality Database. WHO Statistical Information System. http://www.who.int/whosis/mort/download/en/index.html. Accessed Feb 2010
17. Office of National Statistics (1998-2008) Cancer Statistics: Registrations: Registrations of cancer diagnosed in 1992; 1993;1994; 1995-1997; 1998; 1999; 2003; 2004; 2005; 2006, England and Wales. vol Series MB1 No.: 25-30; 34-37 Office of National Statistics
18. Jakomis N (2010) Cancer incidences ENGLAND 1992-1994. Office of National Statistics, London
19. Boyle P, Parkin, DM (1991) Chapter 11: Statistical Methods for Registries. In: Jensen OM, Parkin, DM, MacLennan, R., Muir, CS., Skeet, RG. (ed) Cancer Registration: Principles and Methods. IARC Press, Lyon, France
20. Doll R, Payne P, Waterhouse JAH (1966) Cancer Incidence in five continents, vol I. Union Internationale Contre le Cancer, Geneva
21. Australian Institute of Health and Welfare (2009) Cervical Screening in Australia 2006-2007. Australian Institute of Health and Welfare Cat. No. CAN 43 Cancer Series Number 47, Canberra
22. Brewer N, McKenzie F, Wong KC, Ellison-Loschmann L (2009) National cervical screening programme annual monitoring report 2007, vol 26. Centre for Public Health Research, Massey University, NZ, Wellington, New Zealand
23. Brewer N, McKenzie F, Wong KC, Eillison-Loschmann L (2008) NCSP Annual Monitoring Report 2006, Centre for Public Health Research. Massey University, Wellington, New Zealand
24. Brewer N, McKenzie F, Wong KC, Eillison-Loschmann L (2007) NCSP annual monitoring report 2005. Centre for Public Health Research, Massey University, Wellington, New Zealand
25. Brewer N, McKenzie F, Travier N, Jeffreys M (2007) NCSP annual monitoring report 2004. Centre for Public Health Research, Massey University, Wellington, New Zealand
26. Coppell K (2003) NCSP annual monitoring report 2003. Wellington, New Zealand
27. Coppell K (2003) NCSP annual monitoring report 2002. Wellington, New Zealand
28. Coppell K, Cox B (2002) National cervical screening programme October-December 2001. Hugh Adam Cancer Epidemiology Unit University of Otago, Dunedin, New Zealand
29. Coppell K, Cox B (2001) National Cervical Screening Programme October-December 2000. Hugh Adam Cancer Epidemiology Unit University of Otago, Dunedin, New Zealand
30. Cervical Screening Programme, England 2009-10 (2010) http://www.ic.nhs. uk/statistics-and-data-collections/screening/cervical-screening/ cervical-screening-programme-england-2009-10. Accessed Feb 2011
31. National Health Service Cancer Screening Programmes (2000) Reducing the risk: cervical screening programme 2000. NHS Cervical Screening Programme, National Health Service, Sheffield
32. Cervical Screening Programme, England 2004-5 (2005) The Health and Social Care Information Centre,. http://www.ic.nhs.uk/statistics-and-data-collections/ screening/cervical-cancer/cervical-screening-programme-england-2004-05. Accessed Feb 2011
33. National Health Service Cancer Screening Programmes (2002) Building on experience: cervical screening programme 2002. NHS Cervical Screening Programme, National Health Service, Sheffield
34. Quinn M, Babb P, Jones J, Allen E (1999) Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 318(7188):904-908
35. Foley G, Alston R, Geraci M, Brabin L, Kitchener H, Birch J (2011) Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006. Br J Cancer 105(1):177-184
36. Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O'Reilly M, Andrae B (2009) The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J cancer (Oxford, England: 1990) 45(15):2671-2678
37. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A (2009) Trends of cervical cancer mortality in the member states of the European Union. Eur J cancer (Oxford, England: 1990) 45(15):2640-2648
38. Ferlay J, Parkin, DM., Curado, MP., Bray, F., Edwards, B., Shin, HR., Forman, D (2010) Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9. Accessed Feb 2011
39. Taylor RJ, Morrell SL, Mamoon HA, Wain GV (2001) Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort. J Epidemiol Commun Health 55(11):782-788
40. Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M, Sweetland S, Cancer ICoESoC (2007) Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 370 (9599):1609-1621
41. The International Collaboration of Epidemiological Studies of Cervical Cancer (2006) Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 119(5):1108-1124
42. Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodill A, Green J, Peto J, Plummer M, Sweetland S (2006) Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 118(6):1481-1495
43. The World Bank (2011) The world bank data indicators: contraceptive prevalence (% of women ages 15-49). http://data.worldbank.org/indicator/SP.DYN. CONU.ZS. 2011
44. United Nations (2008) World Population Prospects: the 2008 revision and World Urbanization Prospects: the 2008 revision. http://esa.un.org/unpp/index. asp?panel=2
45. The World Bank (2011) The world bank data indicators: fertility rate, total (births per woman). http://data.worldbank.org/indicator/SP.DYN.TFRT.IN. 2011
46. Australian Institute of Health (2005) statistics on drug use in Australia 2004. Department of health and ageing, drug statistics series no. 15, Canberra
47. Legood R, Wolstenholme J, Gray A (2009) From cost-effectiveness information to decision-making on liquid-based cytology: mind the gap. Health Policy 89(2):193-200
48. Cervix cancer screening/IARC Working Group on the Evaluation of Cancer Preventive Strategies (2005) Chapter 2: Screening tests. In. IARC Handbooks of Cancer Prevention, vol 2, 10 edn. IARC Press, pp 59-117
49. Patel A, Galaal K, Burnley C, Faulkner K, Martin-Hirsch P, Bland MJ, Leeson S, Beer H, Paranjothy S, Sasieni P, Naik R (2012) Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study. Br J Cancer 106(11):1753-1759
50. Taylor R, Morrell S, Mamoon H, Wain G, Ross J (2006) Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia). Cancer causes control: CCC 17(3):299-306
51. Wise J (2012) Pilot study will assess whether HPV test should replace smears to screen for cervical cancer. BMJ 344:e3744
52. Kitchener HC, Gilham C, Sargent A, Bailey A, Albrow R, Roberts C, Desai M, Mather J, Turner A, Moss S, Peto J (2011) A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J cancer (Oxford, England: 1990) 47(6):864-871
53. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F, Franco EL (2007) Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J med 357(16):1579-1588
54. Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, Malila N, Nieminen P (2010) Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ 340:c1804
55. Bulk S, Bulkmans NW, Berkhof J, Rozendaal L, Boeke AJ, Verheijen RH, Snijders PJ, Meijer CJ (2007) Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months. Int J Cancer 121(2):361-367
56. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, Ruitinga W, van Ballegooijen M, Snijders PJ, Meijer CJ (2007) Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370(9601):1764-1772
57. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet oncol 11(3):249-257